NTT
1.9.2021 10:02:12 CEST | Business Wire | Press release
NTT Ltd.’s Global Data Centers division , a Leader in the IDC MarketScape Worldwide Data Center Colocation and Interconnection Services 2021 Vendor Assessment1 , provides a full stack of ICT services and continues to expand its global data center footprint by 20% to build a connected future that will benefit enterprise and hyperscale clients around the world.
NTT operates data centers across Europe, North America, Africa, and Asia, including a major presence in India. It delivers and operates global interconnected data centers with cross regional data center networks through key markets such as London, Singapore, Tokyo, and Virginia in North America. Its expansions in data center services provide increased data center capacity and network connectivity across all geographies, including:
- Americas:
In 2020/21, three new data center campuses were opened in Hillsboro, OR, Santa Clara, CA, and Chicago, IL, in addition to expansion in Ashburn, VA. NTT’s 47-acre (approx. 190,000m2 ) Hillsboro campus features five data centers with 126MW of planned IT load and Subsea Connect, a trans-pacific network connectivity service that provides connectivity between Hillsboro, Oregon and Tokyo, Japan using NTT’s Pacific Crossing (PC-1) subsea cable system. The Phoenix, AZ campus will open in early 2022 and be the seventh US data center campus. NTT Phoenix PH1 will add 36MW of IT load capacity and is the first of seven planned data centers on the 240MW campus.
- EMEA:
In the past year, NTT has opened new data center buildings in Amsterdam in the Netherlands, and Munich and Frankfurt in Germany, continuing its position as the number one data center provider in the German market. In the UK, the new flagship London 1 Data Center opened in December and, when fully operational, will increase NTT’s capacity by over 200% to support the digital backbone of the UK’s financial services, media, and gaming industries. NTT has also invested in duct and fiber to interconnect all its London data centers.
Over the next two years, NTT will increase its available IT load in EMEA by over 40% as it builds 13 new data center buildings across nine markets in six countries to deliver an added 115MW of IT load across 50,000m2 . NTT will launch its first data centers in Madrid and Johannesburg as well as adding buildings to Vienna, Zurich, London and across Germany, with expanded data center interconnections.
- APAC:
Jakarta 3 in Indonesia will launch 15MW at Bekasi, approximately 30km from Central Jakarta, by the end of this year. By taking advantage of NTT’s strengths as a network operator, clients will be able to easily connect with IXs and ISPs. Additionally, Cyberjaya 5 in Malaysia started to provide 6.8MW and plan to expand another 6.8MW to the Cyberjaya campus. In Japan, a new data center with 21MW of IT load capacity has been built in Tokyo. In response to strong demand from its clients, NTT is considering further expansion in Bangkok (Thailand), Osaka Metropolitan area (Japan), and Southern Vietnam.
- India:
With Mumbai 8 going live soon, the Chandivali campus, India’s first operational hyperscale data center park, will reach 85MW of IT load. Over the next 18 months, four new hyperscale data center parks will also become operational: two in Navi Mumbai and one each in Chennai and Delhi, adding approximately 133MW of IT load and 50,000m2 of floorspace. Interconnections for 10 data centers across India will also be rolled out in 2021 and submarine cable landing stations are planned in Mumbai and Chennai. This expansion will further consolidate NTT’s number one position in the Indian market.
In addition to the expansion of NTT’s global data center footprint, NTT is currently constructing a "MIST" large-capacity submarine cable connecting Singapore, Malaysia, and India (Mumbai and Chennai).
The MIST cable system will have a total length of 11,000km: a distance which is further than flying from New York, across the US and the Pacific Ocean to land in Tokyo. Construction will complete in mid-2023.
The infrastructure combination of such a significant increase in global data center capacity coupled with NTT’s status as a tier 1 global network service provider, will provide businesses with a secure platform for increasing full-stack ICT service needs.
Global Data Center Interconnect (GDCI) , an integrated global network fabric service that delivers a cross regional data center network and private secure connection to major cloud service providers with a single physical port supporting multiple virtual network services, increases this capability to provide a high speed interconnected digital backbone across its global markets. The increased submarine cable system will also help to provide cross-regional data center interconnections.
Masaaki Moribayashi, President and Board Director for NTT Ltd. said, “The pandemic has dramatically changed our way of life. People’s quality of life now fundamentally depends on this infrastructure. In the next 18 months, NTT plans to increase data center operations by 20% to a total of over 600,000m2 (approx. 6.5M ft2 ) of floorspace in over 20 countries and regions. In addition, NTT will globally expand approximately 30 connection points of GDCI service in our data centers to optimize the enterprise hybrid cloud environment over NTT’s data centers and network services. NTT has already started construction to add 300MW of IT load to its portfolio. With the completion of new data centers, expanded campuses and high capacity networks such as the MIST submarine cable, we are building a connected future that will benefit NTT's clients around the world.”
To contact us about your project and to see the full extent of NTT’s Global Data Center footprint, services and builds visit https://datacenter.hello.global.ntt
1 IDC MarketScape: Worldwide Datacenter Colocation and Interconnection Services 2021
-ENDS-
About the Global Data Centers division of NTT Ltd.
Global Data Centers is a division of NTT Ltd. Our global platform is one of the largest in the world. NTT is recognized as a Leader by IDC in the Worldwide Colocation and Interconnection Services MarketScape, spanning more than 20 countries and regions including North America, Europe, Africa, India and APAC. As a neutral operator, we offer access to multiple cloud providers, a large variety of Internet Exchanges and telecommunication network providers including our own IPv6 compliant, tier-one global IP network. Our clients benefit from tailored infrastructure and experience consistent best practices in design and operations across all of our reliable, scalable and customizable data centers.
Visit us at our new website datacenter.hello.global.ntt .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210901005069/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally25.2.2026 08:07:00 CET | Press release
The investor consortium comprising the Paris-based Next Generation Fuels Industrial & Technological fund Calderion (Audacia), alongside infrastructure developer Terravent and WenCo Family Office, announces the closing of a strategic double-digit million-euro financing round for Berlin-based Graforce GmbH. The investment is dedicated to the industrial scale-up of Graforce’s proprietary plasma pyrolysis technology, addressing the growing global demand for cost-efficient low-carbon hydrogen, syngas, and carbon removal solutions that are compatible with existing industrial infrastructures. Disruptive alternative to conventional processes Graforce’s technology aims at replacing CO₂-intensive legacy routes such as steam reforming and classical gasification. By applying plasma to methane, biogas, flare gas, and landfill gas, the process converts these streams into their valuable molecular components instead of emitting them. The result is a high-efficiency production of clean hydrogen and syn
Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy25.2.2026 08:00:00 CET | Press release
CE Marking enables marketing and clinical use of the world’s first and only LINAC vault-ready proton therapy system across the European Union Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has received CE Marking under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone enables the marketing, sale, and clinical use of the MEVION S250-FIT system throughout the European Union, building on the system’s existing U.S. FDA 510(k) clearance granted in September 2025. The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION S250-FIT dramatically reduces the cost, complexity, and timeline traditionally associated with proton therapy adoption. This opens a new pathway for hospitals and cancer centers a
Bureau Veritas:Sector-Leading Organic Revenue Growth of 6.5% in FY 202525.2.2026 07:30:00 CET | Press release
Strong margin improvement to 16.3% in FY 2025Positive growth outlook with continued margin expansion in 2026New EUR 200 million share buyback Bureau Veritas (BOURSE:BVI): 2025 key figures1 › Full-year revenue of EUR 6,466.4 million, up 6.5% organically (with 6.3% organic growth in Q4). At constant currency, the growth was up 7.3% year-on-year and up 3.6% on a reported basis, › Adjusted operating profit of EUR 1,052.9 million, up 5.7% versus EUR 996.2 million in FY 2024, representing an adjusted operating margin of 16.3%, up 32 basis points year-on-year and up 51 basis points at constant currency, › Operating profit of EUR 992.4 million, up 6.3% versus EUR 933.4 million in FY 2024, › Adjusted net profit of EUR 631.4 million, up 1.7% versus EUR 620.7 million in FY 2024, › Adjusted EPS stood at EUR 1.42 in 2025, with a 2.8% increase versus FY 2024 (EUR 1.38 per share) and up 9.2% at constant currency, › Attributable net profit of EUR 588.0 million, up 3.3% versus EUR 569.4 million in FY 2
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics25.2.2026 07:00:00 CET | Press release
Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane®syringe for use with a range of Restylane NASHA® lidocaine products in multiple indications in the face and in the hands1-3 Developed in collaboration with aesthetic practitioners, its innovative ergonomic design features a cushioned finger grip and thumb rest, to improve practitioner experience through better injection comfort and control, helping them deliver consistently premium results 4-7 The syringe’s carton packaging is the first in the industry to be made from 100% recyclable paper, and reaffirms Galderma’s commitment to sustainability and environmental responsibility 8 These approvals demonstrate Galderma’s strong heritage in Injectable Aesthetics, and its commitment to continuing to drive innovation in the field Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-ar
Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis25.2.2026 07:00:00 CET | Press release
Preclinical proof-of-concept data in GM2 gangliosidosis demonstrated survival benefit, functional improvement and target engagementResults are published in the 7 January issue of the Journal of Inherited Metabolic DiseaseNizubaglustat is currently in Phase 3 registrational studies in GM1/GM2 gangliosidoses and Niemann-Pick type C disease (NPC) Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept preclinical data with its lead product, nizubaglustat, in GM2 gangliosidosis. The data, published in the 7 January issue of the Journal of Inherited Metabolic Disease in collaboration with the laboratory of Dr. Jagdeep Walia, Department of Pediatrics, Queen's University, Kingston, Canada, reinforce nizubaglustat’s potential to address unmet needs in rare LSDs and build on existing preclinical and clinical evidence. The preclinical study tested nizubaglustat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
